506285 Stock Overview
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Bayer CropScience Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹5,716.20 |
| 52 Week High | ₹6,202.00 |
| 52 Week Low | ₹4,028.00 |
| Beta | 0.34 |
| 1 Month Change | 13.66% |
| 3 Month Change | -1.02% |
| 1 Year Change | 39.41% |
| 3 Year Change | 11.47% |
| 5 Year Change | 39.54% |
| Change since IPO | 7,521.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| 506285 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 4.4% | -2.5% | -2.5% |
| 1Y | 39.4% | 17.2% | 44.5% |
Return vs Industry: 506285 exceeded the Indian Chemicals industry which returned 17.2% over the past year.
Return vs Market: 506285 underperformed the Indian Market which returned 44.5% over the past year.
Price Volatility
| 506285 volatility | |
|---|---|
| 506285 Average Weekly Movement | 4.4% |
| Chemicals Industry Average Movement | 6.4% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: 506285 has not had significant price volatility in the past 3 months.
Volatility Over Time: 506285's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1863 | 1,321 | Simon Wiebusch | www.bayer.in |
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines primarily in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and diagnostic imaging equipment and other contrast agents, including computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes hybrid seeds, such as corn and paddy.
Bayer CropScience Limited Fundamentals Summary
| 506285 fundamental statistics | |
|---|---|
| Market cap | ₹249.43b |
| Earnings (TTM) | ₹8.03b |
| Revenue (TTM) | ₹52.94b |
32.0x
P/E Ratio4.9x
P/S RatioIs 506285 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 506285 income statement (TTM) | |
|---|---|
| Revenue | ₹52.94b |
| Cost of Revenue | ₹30.31b |
| Gross Profit | ₹22.64b |
| Other Expenses | ₹14.61b |
| Earnings | ₹8.03b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 178.67 |
| Gross Margin | 42.76% |
| Net Profit Margin | 15.17% |
| Debt/Equity Ratio | 2.0% |
How did 506285 perform over the long term?
See historical performance and comparison